Cargando…
ERα-36 regulates progesterone receptor activity in breast cancer
BACKGROUND: Alterations in estrogen and progesterone signaling, via their respective receptors, estrogen receptor alpha (ERα) and progesterone receptor (PR), respectively, are largely involved in the development of breast cancer (BC). The recent identification of ERα-36, a splice variant of ERα, has...
Autores principales: | Konan, Henri-Philippe, Kassem, Loay, Omarjee, Soleilmane, Surmieliova-Garnès, Ausra, Jacquemetton, Julien, Cascales, Elodie, Rezza, Amélie, Trédan, Olivier, Treilleux, Isabelle, Poulard, Coralie, Le Romancer, Muriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238515/ https://www.ncbi.nlm.nih.gov/pubmed/32429997 http://dx.doi.org/10.1186/s13058-020-01278-7 |
Ejemplares similares
-
The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer
por: Choucair, Ali, et al.
Publicado: (2019) -
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα
(+) breast cancer
por: Poulard, Coralie, et al.
Publicado: (2023) -
The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer
por: Omarjee, S, et al.
Publicado: (2017) -
PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer
por: Noureddine, Lara Malik, et al.
Publicado: (2023) -
PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer
por: Malbeteau, Lucie, et al.
Publicado: (2022)